Alzheimer's disease & dementia

A new drug could slow Alzheimer's: But can patients get it?

It's welcome news for Alzheimer's patients and their families: A Food and Drug Administration advisory panel unanimously recommended approval for Eli Lilly & Co.'s treatment donanemab. If given the agency's green light later ...

page 1 from 40